Stay updated on IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial page.

Latest updates to the IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial page
- Check5 days agoChange DetectedA minor update to the website’s revision/version label was made, changing the displayed revision from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check12 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check41 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 in the Record History.SummaryDifference0.1%

- Check48 days agoChange DetectedAdded revision v3.4.3 and removed revision v3.4.2 from the page history.SummaryDifference0.1%

- Check77 days agoChange DetectedA new Revision: v3.4.2 entry was added to the history, and older items such as the government funding notice and Revision: v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check84 days agoChange DetectedAdded a government funding status notice and updated the revision tag to v3.4.1, replacing the previous v3.4.0 reference.SummaryDifference0.6%

Stay in the know with updates to IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial page.